CRVS EPS Estimates
Corvus Pharmaceuticals, Inc.
$11.01
-$0.46(-4.01%)
39
Overall
40
Value
40
Tech
39
Quality
Market Cap
$928.73M
Volume
253.44K
52W Range
$6.39 - $26.95
Target Price
$32.71
CRVS EPS estimates: the consensus estimate for Corvus Pharmaceuticals, Inc.'s current fiscal year is -$0.79 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CRVS EPS Estimates
- EPS estimate, current quarter
- $-0.21
- EPS estimate, next quarter
- $-0.22
- EPS estimate, current year
- $-0.79
- EPS estimate, next year
- $-1.06
- EPS growth, 3-year
- +40.23%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.19 |
| 2024 | $-1.02 |
| 2023 | $-0.56 |
| 2022 | $-0.89 |
| 2021 | $-1.03 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRVS | $11.01 | -4.0% | 253.44K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corvus Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW